1Wahle, KW, Heys, SD & Rotondo, D (2004) Conjugated linoleic acids: are they beneficial or detrimental to health? Prog Lipid Res 43, 553–587.
2Dhiman, TR, Nam, SH & Ure, AL (2005) Factors affecting conjugated linoleic acid content in milk and meat. Crit Rev Food Sci Nutr 45, 463–482.
3Yurawecz, MP, Roach, JA, Sehat, N, et al. (1998) A new conjugated linoleic acid isomer, 7 trans, 9 cis-octadecadienoic acid, in cow milk, cheese, beef and human milk and adipose tissue. Lipids 33, 803–809.
4Sehat, N, Kramer, JK, Mossoba, MM, et al. (1998) Identification of conjugated linoleic acid isomers in cheese by gas chromatography, silver ion high performance liquid chromatography and mass spectral reconstructed ion profiles. Comparison of chromatographic elution sequences. Lipids 33, 963–971.
5Evans, M, Brown, J & McIntosh, M (2002) Isomer-specific effects of conjugated linoleic acid (CLA) on adiposity and lipid metabolism. J Nutr Biochem 13, 508–516.
6Rodriguez, E, Ribot, J & Palou, A (2002) Trans-10, cis-12, but not cis-9, trans-11 CLA isomer, inhibits brown adipocyte thermogenic capacity. Am J Physiol Regul Integr Comp Physiol 282, R1789–R1797.
7Tricon, S, Burdge, GC, Kew, S, et al. (2004) Opposing effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr 80, 614–620.
8Park, Y, Storkson, JM, Albright, KJ, et al. (1999) Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 34, 235–241.
9Ryder, JW, Portocarrero, CP, Song, XM, et al. (2001) Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes 50, 1149–1157.
10Hargrave, KM, Li, C, Meyer, BJ, et al. (2002) Adipose depletion and apoptosis induced by trans-10, cis-12 conjugated linoleic acid in mice. Obes Res 10, 1284–1290.
11Henriksen, EJ, Teachey, MK, Taylor, ZC, et al. (2003) Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat. Am J Physiol Endocrinol Metab 285, E98–E105.
12Park, Y, Albright, KJ, Storkson, JM, et al. (1999) Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids 34, 243–248.
13Evans, M, Lin, X, Odle, J, et al. (2002) Trans-10, cis-12 conjugated linoleic acid increases fatty acid oxidation in 3T3-L1 preadipocytes. J Nutr 132, 450–455.
14West, DB, Delany, JP, Camet, PM, et al. (1998) Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol 275, R667–R672.
15Brown, JM, Halvorsen, YD, Lea-Currie, YR, et al. (2001) Trans-10, cis-12, but not cis-9, trans-11, conjugated linoleic acid attenuates lipogenesis in primary cultures of stromal vascular cells from human adipose tissue. J Nutr 131, 2316–2321.
16Kang, K, Liu, W, Albright, KJ, et al. (2003) Trans-10, cis-12 CLA inhibits differentiation of 3T3-L1 adipocytes and decreases PPAR γ expression. Biochem Biophys Res Commun 303, 795–799.
17West, DB, Blohm, FY, Truett, AA, et al. (2000) Conjugated linoleic acid persistently increases total energy expenditure in AKR/J mice without increasing uncoupling protein gene expression. J Nutr 130, 2471–2477.
18Tsuboyama-Kasaoka, N, Takahashi, M, Tanemura, K, et al. (2000) Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49, 1534–1542.
19Choi, JS, Jung, MH, Park, HS, et al. (2004) Effect of conjugated linoleic acid isomers on insulin resistance and mRNA levels of genes regulating energy metabolism in high-fat-fed rats. Nutrition 20, 1008–1017.
20Roche, HM, Noone, E, Sewter, C, et al. (2002) Isomer-dependent metabolic effects of conjugated linoleic acid: insights from molecular markers sterol regulatory element-binding protein-1c and LXRα. Diabetes 51, 2037–2044.
21Riserus, U, Arner, P, Brismar, K, et al. (2002) Treatment with dietary trans10,cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 25, 1516–1521.
22Steppan, CM & Lazar, MA (2002) Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 13, 18–23.
23Tsao, TS, Lodish, HF & Fruebis, J (2002) ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 440, 213–221.
24Statnick, MA, Beavers, LS, Conner, LJ, et al. (2000) Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 1, 81–88.
25Steppan, CM, Bailey, ST, Bhat, S, et al. (2001) The hormone resistin links obesity to diabetes. Nature 409, 307–312.
26Li, J, Yu, X, Pan, W, et al. (2002) Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity. Am J Physiol Endocrinol Metab 282, E1334–E1341.
27Berg, AH, Combs, TP, Du, X, et al. (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7, 947–953.
28Fruebis, J, Tsao, TS, Javorschi, S, et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98, 2005–2010.
29Holst, D & Grimaldi, PA (2002) New factors in the regulation of adipose differentiation and metabolism. Curr Opin Lipidol 13, 241–245.
30Berge, RK, Flatmark, T & Osmundsen, H (1984) Enhancement of long-chain acyl-CoA hydrolase activity in peroxisomes and mitochondria of rat liver by peroxisomal proliferators. Eur J Biochem 141, 637–644.
31Willumsen, N, Hexeberg, S, Skorve, J, et al. (1993) Docosahexaenoic acid shows no triglyceride-lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats. J Lipid Res 34, 13–22.
32Madsen, L, Froyland, L, Dyroy, E, et al. (1998) Docosahexaenoic and eicosapentaenoic acids are differently metabolized in rat liver during mitochondria and peroxisome proliferation. J Lipid Res 39, 583–593.
33Alam, N & Saggerson, ED (1998) Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle. Biochem J 334, 233–241.
34Small, GM, Burdett, K & Connock, MJ (1985) A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. Biochem J 227, 205–210.
35Clinkenbeard, KD, Reed, WD, Mooney, RA, et al. (1975) Intracellular localization of the 3-hydroxy-3-methylglutaryl coenzyme A cycle enzymes in liver. Separate cytoplasmic and mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A generating systems for cholesterogenesis and ketogenesis. J Biol Chem 250, 3108–3116.
36Tanabe, T, Nakanishi, S, Hashimoto, T, et al. (1981) Acetyl-CoA carboxylase from rat liver. Methods Enzymol 71, 5–16.
37Roncari, DA (1981) Fatty acid synthase from human liver. Methods Enzymol 71, 73–79.
38Skorve, J, al-Shurbaji, A, Asiedu, D, et al. (1993) On the mechanism of the hypolipidemic effect of sulfur-substituted hexadecanedioic acid (3-thiadicarboxylic acid) in normolipidemic rats. J Lipid Res 34, 1177–1185.
39Bates, EJ & Saggerson, D (1977) A selective decrease in mitochondrial glycerol phosphate acyltransferase activity in livers from streptozotocin-diabetic rats. FEBS Lett 84, 229–232.
40Wergedahl, H, Liaset, B, Gudbrandsen, OA, et al. (2004) Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. J Nutr 134, 1320–1327.
41Bligh, EG & Dyer, WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911–917.
42Ribot, J, Felipe, F, Bonet, ML, et al. (2001) Changes of adiposity in response to vitamin A status correlate with changes of PPAR γ 2 expression. Obes Res 9, 500–509.
43Jacobsson, A, Stadler, U, Glotzer, MA, et al. (1985) Mitochondrial uncoupling protein from mouse brown fat. Molecular cloning, genetic mapping, and mRNA expression. J Biol Chem 260, 16250–16254.
44Trayhurn, P, Duncan, JS, Nestor, A, et al. (1994) Chemiluminescent detection of mRNAs on Northern blots with digoxigenin end-labeled oligonucleotides. Anal Biochem 222, 224–230.
45Sanders, SR, Teachey, MK, Ptock, A, et al. (2004) Effects of specific conjugated linoleic acid isomers on growth characteristics in obese Zucker rats. Lipids 39, 537–543.
46Clement, L, Poirier, H, Niot, I, et al. (2002) Dietary trans-10, cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res 43, 1400–1409.
47Kelley, DS, Bartolini, GL, Warren, JM, et al. (2004) Contrasting effects of t10,c12- and c9,t11-conjugated linoleic acid isomers on the fatty acid profiles of mouse liver lipids. Lipids 39, 135–141.
48Degrace, P, Demizieux, L, Gresti, J, et al. (2003) Association of liver steatosis with lipid oversecretion and hypotriglyceridaemia in C57BL/6j mice fed trans-10, cis-12-linoleic acid. FEBS Lett 546, 335–339.
49Warren, JM, Simon, VA, Bartolini, G, et al. (2003) Trans-10, cis-12 CLA increases liver and decreases adipose tissue lipids in mice: possible roles of specific lipid metabolism genes. Lipids 38, 497–504.
50Rahman, SM, Huda, MN, Uddin, MN, et al. (2002) Short-term administration of conjugated linoleic acid reduces liver triglyceride concentration and phosphatidate phosphohydrolase activity in OLETF rats. J Biochem Mol Biol 35, 494–497.
51Wang, Y-M, Rahman, SM, Nagao, K, et al. (2003) Conjugated linoleic acid reduces hepatic microsomal triacylglycerol transfer protein activity and hepatic triacylglycerol mass in obese rats. J Oleo Sci 52, 129–134.
52Nagao, K, Inoue, N, Wang, YM, et al. (2005) Dietary conjugated linoleic acid alleviates nonalcoholic fatty liver disease in Zucker (fa/fa) rats. J Nutr 135, 9–13.
53Noto, A, Zahradka, P, Yurkova, N, et al. (2006) Conjugated linoleic acid reduces hepatic steatosis, improves liver function, and favorably modifies lipid metabolism in obese insulin-resistant rats. Lipids 41, 179–188.
54Degrace, P, Demizieux, L, Gresti, J, et al. (2004) Hepatic steatosis is not due to impaired fatty acid oxidation capacities in C57BL/6J mice fed the conjugated trans-10, cis-12-isomer of linoleic acid. J Nutr 134, 861–867.
55Moya-Camarena, SY, Vanden Heuvel, JP, Blanchard, SG, et al. (1999) Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARα. J Lipid Res 40, 1426–1433.
56Belury, MA, Moya-Camarena, SY, Lu, M, et al. (2002) Conjugated linoleic acid is an activator and ligand for peroxisome proliferator-activated receptor-γ (PPARγ). Nutr Res 22, 817–824.
57Park, Y, Storkson, JM, Ntambi, JM, et al. (2000) Inhibition of hepatic stearoyl-CoA desaturase activity by trans-10, cis-12 conjugated linoleic acid and its derivatives. Biochim Biophys Acta 1486, 285–292.
58Bretillon, L, Chardigny, JM, Gregoire, S, et al. (1999) Effects of conjugated linoleic acid isomers on the hepatic microsomal desaturation activities in vitro. Lipids 34, 965–969.
59Miyazaki, M, Kim, YC, Gray-Keller, MP, et al. (2000) The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J Biol Chem 275, 30132–30138.
60Legrand, P, Catheline, D, Fichot, MC, et al. (1997) Inhibiting Δ9-desaturase activity impairs triacylglycerol secretion in cultured chicken hepatocytes. J Nutr 127, 249–256.
61Sebedio, JL, Angioni, E, Chardigny, JM, et al. (2001) The effect of conjugated linoleic acid isomers on fatty acid profiles of liver and adipose tissues and their conversion to isomers of 16 : 2 and 18 : 3 conjugated fatty acids in rats. Lipids 36, 575–582.
62Videla, LA, Rodrigo, R, Araya, J, et al. (2004) Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radic Biol Med 37, 1499–1507.
63Clarke, SD (2001) Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J Nutr 131, 1129–1132.
64Lin, Y, Kreeft, A, Schuurbiers, JA, et al. (2001) Different effects of conjugated linoleic acid isomers on lipoprotein lipase activity in 3T3-L1 adipocytes. J Nutr Biochem 12, 183–189.
65Xu, X, Storkson, J, Kim, S, et al. (2003) Short-term intake of conjugated linoleic acid inhibits lipoprotein lipase and glucose metabolism but does not enhance lipolysis in mouse adipose tissue. J Nutr 133, 663–667.
66Yamasaki, M, Ikeda, A, Oji, M, et al. (2003) Modulation of body fat and serum leptin levels by dietary conjugated linoleic acid in Sprague–Dawley rats fed various fat-level diets. Nutrition 19, 30–35.
67De Vos, P, Lefebvre, AM, Miller, SG, et al. (1996) Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ. J Clin Invest 98, 1004–1009.
68Nagao, K, Inoue, N, Wang, YM, et al. (2003) Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in Zucker diabetic fatty (fa/fa) rats. Biochem Biophys Res Commun 310, 562–566.
69Poirier, H, Rouault, C, Clement, L, et al. (2005) Hyperinsulinaemia triggered by dietary conjugated linoleic acid is associated with a decrease in leptin and adiponectin plasma levels and pancreatic β cell hyperplasia in the mouse. Diabetologia 48, 1059–1065.
70Boyd, ME, Albright, EB, Foster, DW, et al. (1981) In vitro reversal of the fasting state of liver metabolism in the rat. Reevaluation of the roles of insulin and glucose. J Clin Invest 68, 142–152.
71McGarry, JD (2001) Travels with carnitine palmitoyltransferase I: from liver to germ cell with stops in between. Biochem Soc Trans 29, 241–245.
72Sisk, MB, Hausman, DB, Martin, RJ, et al. (2001) Dietary conjugated linoleic acid reduces adiposity in lean but not obese Zucker rats. J Nutr 131, 1668–1674.
73Azain, MJ, Hausman, DB, Sisk, MB, et al. (2000) Dietary conjugated linoleic acid reduces rat adipose tissue cell size rather than cell number. J Nutr 130, 1548–1554.